iHuman Inc (IH) FinancialsIHiHuman Inc

Evaluating the bottom line, iHuman Inc maintains a gross margin of 66.84%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -5.53%, while the net margin is 2.47%. These profitability ratios, combined with a Return on Equity (ROE) of 7.73%, provide a clear picture of how effectively IH converts its operational activities into shareholder value.

In the context of the broader market, IH competes directly with industry leaders such as NIPG and CAST. With a market capitalization of $63.89M, it holds a significant position in the sector. When comparing efficiency, IH's gross margin of 66.84% stands against NIPG's -1.17% and CAST's 62.96%. Such benchmarking helps identify whether iHuman Inc is trading at a premium or discount relative to its financial performance.

iHuman's financial performance shows a troubling trend with total revenue decreasing from CNY 239.4 million in Q3 2024 to CNY 182.5 million in Q1 2026. The net income also dropped significantly, indicating potential issues in maintaining profitability.